Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40939

EIF2AK2 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The EIF2AK2 Knockout HEK293T Polyclonal Cells provide a heterogeneous CRISPR/Cas9-edited population for loss-of-function studies of the dsRNA-activated kinase PKR. Derived from HEK293T cells, this model enables investigation of PKR-dependent innate immune signaling, translational control, and stress responses without clonal variability. PKR phosphorylates eIF2?? to inhibit global translation while inducing ATF4-driven stress gene expression, and also activates NF-??B and MAPK pathways. Applications include antiviral immunity research, translational profiling, drug screening, and apoptosis assays. Researchers can use these cells for luciferase reporter systems, RNA-seq, co-immunoprecipitation, and complementation experiments. For details, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    EIF2AK2

    Gene Identifier

    NCBI Gene ID 5610

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EIF2AK2 Knockout HEK293T Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout population for loss-of-function analysis of EIF2AK2, encoding the dsRNA-activated protein kinase R (PKR). Generated by introducing CRISPR/Cas9 reagents targeting the EIF2AK2 locus into HEK293T cells and selecting for disruptive edits, this heterogeneous pool serves as a robust model for studying PKR-dependent innate immunity, translational reprogramming, and stress responses, free from clonal artifacts.

The HEK293T host cell line, a derivative of human embryonic kidney HEK293 cells, stably expresses the SV40 large T antigen. This antigen facilitates high-copy episomal replication of plasmids carrying the SV40 origin, making HEK293T cells the workhorse for transient protein overexpression, lentiviral packaging, and inducible gene expression experiments. Their adherent epithelial morphology, rapid growth kinetics, and high transfection efficiency underpin their widespread use in functional genomics and drug discovery.

EIF2AK2 encodes PKR, a serine/threonine kinase that serves as a critical mediator of antiviral innate immunity. PKR is directly activated by double-stranded RNA (dsRNA) as well as by protein activators such as PACT (PRKRA) and poly I:C. Once activated, PKR phosphorylates the ?? subunit of eukaryotic translation initiation factor 2 (eIF2??) at Ser51, leading to a global attenuation of cap-dependent translation. Concomitantly, this phosphorylation event promotes the selective translation of ATF4, a transcription factor that upregulates stress-responsive genes such as CHOP (DDIT3) and GADD34 (PPP1R15A). In addition to its translational control functions, PKR stimulates NF-??B signaling through activation of the IKK complex and engages the MAPK cascades c-Jun N-terminal kinase (JNK) and p38. PKR also directly phosphorylates p53, insulin receptor substrate 1 (IRS1), and B56??. The kinase is regulated through interactions with ADAR1, ribosomal protein L18, TRAF2, and its endogenous inhibitor p58IPK.

In the HEK293T background, which supports interferon signaling but lacks certain dsRNA sensors such as TLR3, PKR activation is typically induced by exogenous dsRNA or poly I:C transfection. The polyclonal PKR knockout population enables unambiguous discrimination of PKR-dependent from PKR-independent effects on eIF2?? phosphorylation, ATF4 translation, and downstream apoptosis or inflammation. This model is particularly valuable for comparing the contributions of PKR with those of other integrated stress response kinases (PERK, GCN2, HRI) and for examining cross-talk between the PKR pathway and NF-??B or MAPK signaling modules.

Typical applications span mechanistic investigations of translational reprogramming during viral infection, assessment of PKR??s role in dsRNA- or chemotherapy-induced apoptosis, and high-throughput screening for PKR modulators. The deficient cells facilitate luciferase-based reporter assays (ISRE, NF-??B, ATF4), transcriptome-wide profiling by RNA-seq or ribosome profiling, biochemical analysis of PKR complexes via co-immunoprecipitation, and western blot detection of phospho-eIF2?? and downstream effectors. Complementation studies re-introducing wild-type or mutant EIF2AK2 allow dissection of functional domains. For additional technical specifications or custom gene-editing inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)